NCT03296059

Transfusion of Red Blood Cells for Acute Respiratory Distress Syndrome(ARDS) in Neonates

Transfusion of Red Blood Cells for Acute Respiratory Distress Syndrome(ARDS) in Neonates: A Randomized Controlled Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Academic / Other
• Sex: All
• Age: 30 Minutes – 1 Month
• Healthy volunteers: Not accepted

Summary

Acute respiratory distress syndrome (ARDS) in neonates has been defined in 2017. The death rate is over 50%.There are no special treatments for acute respiratory distress syndrome.

Detailed description

Acute respiratory distress syndrome (ARDS) is one of the serious complications in critically ill neonates. It can result in severe hypoxemia refractory to mechanical ventilation. There are few options for mechanical ventilation for such situations such as high frequency oscillation ventilation and extracorporeal membrane oxygenation. The aim of the present study is to determine whether transfusion of red blood cells can decrease the mortality in neonate with ARDS.

Conditions

• Red Blood Cells(RBC)
• Acute Respiratory Distress Syndrome (ARDS)

Interventions

Type	Name	Description
OTHER	conventional treatment with RBC transfusion	Besides conventional treatment, neonates is given RBC transfusion.
OTHER	conventional treatment	neonates is treated with conventional treatment.

Timeline

• Start date: 2017-10-01
• Primary completion: 2024-12-01
• Completion: 2024-12-01
• First posted: 2017-09-28
• Last updated: 2022-10-25

Locations

1 site across 1 country: China